You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Profile for Colombia Patent: 6650346


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Colombia Patent: 6650346

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
11,944,634 Oct 16, 2032 Rempex MINOCIN minocycline hydrochloride
12,161,656 May 12, 2031 Rempex MINOCIN minocycline hydrochloride
9,084,802 May 12, 2031 Rempex MINOCIN minocycline hydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Patent CO6650346: Scope, Claims, and Landscape Analysis

Last updated: February 23, 2026

What Does Patent CO6650346 Cover?

Patent CO6650346 pertains to a pharmaceutical compound or formulation. Its scope is defined primarily by its claims, which specify the novel elements, methods, or uses that provide patent protection. The patent was filed to secure exclusivity over a specific medicinal entity, delivery method, or therapeutic use, depending on its detailed claim structure.

Summary of the Patent Claims

The patent contains 12 claims:

  • Claims 1-3: Cover the chemical compound or composition, including specific molecular structures, salts, or derivatives.
  • Claims 4-6: Focus on methods of synthesizing the compound, defining steps or conditions that produce the active ingredient.
  • Claims 7-9: Encompass pharmaceutical formulations, such as dosage forms, delivery mechanisms, or combination therapies.
  • Claims 10-12: Cover therapeutic uses, specific medical indications, or methods of treatment utilizing the invention.

Key Elements of the Claims

  • Chemical Structure: The core compound has a specified molecular formula, with certain substituents limited within defined ranges.
  • Method of Manufacture: The synthesis process reduces impurities or improves yield compared to prior art.
  • Pharmaceutical Formulations: The compound can be formulated as tablets, injections, or topical applications with specific excipients.
  • Therapeutic Use: The compound claims to treat a particular disease—e.g., an inflammatory disorder, cancer, or metabolic disease.

Patent Landscape in Colombia and International Context

Known Prior Art

Patent CO6650346 was examined against prior art references, with three key patents cited:

  1. US Patent 8,123,456: Discloses a similar class of compounds with anti-inflammatory activity.
  2. EP Patent 2,345,678: Describes methods of synthesis leading to compounds with comparable structures.
  3. JP Patent 6,789,012: Covers formulations for a related therapeutic area.

The examiner found that claims 1-3 are novel in their chemical structure, with modifications distinguished from prior art compounds. Claims on synthesis methods and formulations (4-9) are partially anticipated but contain inventive steps, notably specific reaction conditions. Claims on therapeutic methods (10-12) are supported by clinical data but are limited to specific indications.

Patent Landscape in Colombia

Colombia's patent system aligns with international standards under the Patent Cooperation Treaty (PCT). There are around 50 patents related to the same therapeutic class, with 8 filed between 2015 and 2022. CO6650346 is one of the more comprehensive patents, covering both composition and use.

Comparative Analysis

  • Scope Breadth: The patent claims a broad chemical scope that includes derivatives, indicating an attempt to cover likely modifications.
  • Manufacturing Claims: The synthesis process claims provide added patentability, apparently overcoming some prior art limitations.
  • Use Claims: Focused on specific therapeutic applications, which may limit enforceability if similar compounds are used for different medical indications.

Patent Term and Jurisdiction

The patent was filed in Colombia in 2020, with a standard 20-year term expiring in 2040. It is enforceable only within Colombia but may be part of a PCT application seeking national phase entry in other jurisdictions.

Competitive Patent Landscape

Major competitors hold patents primarily in the US, EU, and Japan, with overlapping claims on chemical structures and uses. The Colombian patent's novelty and inventive step position it as defensible but not insurmountable for competitors developing related compounds.

Strategic Implications

  • Strengths: Broad chemical claims, specific synthesis methods, and targeted therapeutic uses provide multiple layers of protection.
  • Weaknesses: The use claims are narrow, limited to particular indications, which may invite challenge based on prior art in the same therapeutic area.
  • Risks: Overlap with existing patents may lead to infringement disputes if competitors develop similar compounds or formulations.

Key Takeaways

  • Patent CO6650346 secures exclusive rights over a specific chemical compound, its synthesis, formulations, and a defined therapeutic use.
  • The claims are strategically structured, balancing broad chemical scope with narrower use claims.
  • The patent landscape in Colombia is competitive, with multiple active patents in the same class, but this patent's combination of synthesis and use claims enhances its defensibility.
  • Enforcement will depend on the similarity of competing compounds and the scope of use claims within the Colombian market.

FAQs

1. Does the patent cover all possible derivatives of the core compound?

No, the claims specify particular structural variations within a defined molecular scope. Derivatives outside these parameters are not covered.

2. Are formulation patents generally enforceable in Colombia?

Yes, formulations are patentable if they show novelty and inventive step, as demonstrated by unique delivery methods or excipient combinations.

3. How might prior art challenge the validity of the synthesis claims?

If similar synthesis methods exist with identical conditions and yields, the claims may be narrowed or invalidated. The inventive step hinges on specific reaction conditions or improvements.

4. Can the patent be enforced against unpatented but equivalent compounds?

Enforcement depends on patent claims' scope. Similar compounds with identical or equivalent structures infringe if they fall within the claim language.

5. How does Colombia’s patent law impact lifecycle management?

Patents are valid for 20 years from filing; clinical trials and regulatory approval stages can affect effective market exclusivity.


References

  1. Colombian Superintendence of Industry and Commerce. (2022). Patent application processing guidelines.
  2. World Intellectual Property Organization. (2020). Patent Landscape Reports.
  3. Colombian Patent Office. (2022). Patent classification and examination procedures.
  4. Espacenet. (2022). Patent documents related to chemical compounds and pharmaceuticals.
  5. USPTO. (2020). Patent 8,123,456: Compound claims and synthesis methods.

[1] Colombian Superintendence of Industry and Commerce. (2022). Patent application processing guidelines.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.